These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17622112)

  • 61. Optimizing a wet granulation process to obtain high-dose sustained-release tablets with Compritol 888 ATO.
    Rosiaux Y; Girard JM; Desvignes F; Miolane C; Marchaud D
    Drug Dev Ind Pharm; 2015; 41(10):1738-44. PubMed ID: 25652358
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fast-melting tablets based on highly plastic granules.
    Fu Y; Jeong SH; Park K
    J Control Release; 2005 Dec; 109(1-3):203-10. PubMed ID: 16260059
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development of manufacturing method for rapidly disintegrating oral tablets using the crystalline transition of amorphous sucrose.
    Sugimoto M; Narisawa S; Matsubara K; Yoshino H; Nakano M; Handa T
    Int J Pharm; 2006 Aug; 320(1-2):71-8. PubMed ID: 16750604
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmaceutical design of a new lactose-free coprocessed excipient: application of hydrochlorothiazide as a low solubility drug model.
    Viscasillas Clerch A; Fernandez Campos F; Del Pozo A; Calpena Campmany AC
    Drug Dev Ind Pharm; 2013 Jul; 39(7):961-9. PubMed ID: 22607083
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preparation and standardization of a herbal agent for the therapeutic management of asthma.
    Emeje M; Izuka A; Isimi C; Ofoefule S; Kunle O
    Pharm Dev Technol; 2011 Apr; 16(2):170-8. PubMed ID: 20141501
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Potential of carnuba wax in ameliorating brittle fracture during tableting.
    Uhumwangho MU; Okor RS; Adogah JT
    Pak J Pharm Sci; 2009 Jan; 22(1):58-61. PubMed ID: 19168422
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl-beta-cyclodextrin.
    Corti G; Cirri M; Maestrelli F; Mennini N; Mura P
    Eur J Pharm Biopharm; 2008 Feb; 68(2):303-9. PubMed ID: 17616379
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: physicochemical and technological characterisation.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2009 May; 72(1):138-47. PubMed ID: 19146956
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development of a rapidly dispersing tablet of a poorly wettable compound: formulation DOE and mechanistic study of effect of formulation excipients on wetting of celecoxib.
    He X; Barone MR; Marsac PJ; Sperry DC
    Int J Pharm; 2008 Apr; 353(1-2):176-86. PubMed ID: 18207339
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Examining the impact of excipient material property variation on drug product quality attributes: a quality-by-design study for a roller compacted, immediate release tablet.
    Kushner J; Langdon BA; Hiller JI; Carlson GT
    J Pharm Sci; 2011 Jun; 100(6):2222-39. PubMed ID: 21319161
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets.
    Late SG; Yu YY; Banga AK
    Int J Pharm; 2009 Jan; 365(1-2):4-11. PubMed ID: 18778759
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mechanisms of antihyperuricemic effect of Phyllanthus niruri and its lignan constituents.
    Murugaiyah V; Chan KL
    J Ethnopharmacol; 2009 Jul; 124(2):233-9. PubMed ID: 19397979
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Spray dried excipient base: a novel technique for the formulation of orally disintegrating tablets.
    Mishra DN; Bindal M; Singh SK; Vijaya Kumar SG
    Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):99-102. PubMed ID: 16394558
    [TBL] [Abstract][Full Text] [Related]  

  • 74. NEW METHODOLOGY FOR DEVELOPMENT OF ORODISPERSIBLE TABLETS USING HIGH-SHEAR GRANULATION PROCESS.
    Ali BE; Al-Shedfat RI; Fayed MH; Alanazi FK
    Acta Pol Pharm; 2017 May; 74(3):969-981. PubMed ID: 29513967
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Systematical approach of formulation and process development using roller compaction.
    Teng Y; Qiu Z; Wen H
    Eur J Pharm Biopharm; 2009 Oct; 73(2):219-29. PubMed ID: 19406236
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of lubricants on binary direct compression mixtures.
    Uğurlu T; Halaçoğlu MD; Türkoğlu M
    Drug Discov Ther; 2010 Apr; 4(2):123-8. PubMed ID: 22491169
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Direct compression of chitosan: process and formulation factors to improve powder flow and tablet performance.
    Buys GM; du Plessis LH; Marais AF; Kotze AF; Hamman JH
    Curr Drug Deliv; 2013 Jun; 10(3):348-56. PubMed ID: 23545146
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Taste masking microspheres for orally disintegrating tablets.
    Xu J; Bovet LL; Zhao K
    Int J Pharm; 2008 Jul; 359(1-2):63-9. PubMed ID: 18455893
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Roller compaction and tabletting of St. John's wort plant dry extract using a gap width and force controlled roller compactor. II. Study of roller compaction variables on granule and tablet properties by a 3(3) factorial design.
    von Eggelkraut-Gottanka SG; Abed SA; Müller W; Schmidt PC
    Pharm Dev Technol; 2002 Nov; 7(4):447-55. PubMed ID: 12503526
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Spray-dried chitinosans. Part II: in vitro drug release from tablets made from spray-dried chitinosans.
    Rege PR; Garmise RJ; Block LH
    Int J Pharm; 2003 Feb; 252(1-2):53-9. PubMed ID: 12550780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.